Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,650.00
Bid: 1,649.50
Ask: 1,650.50
Change: 35.00 (2.17%)
Spread: 1.00 (0.061%)
Open: 1,631.00
High: 1,663.50
Low: 1,630.50
Prev. Close: 1,615.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks dip despite barrage of positive readings on the economy

Fri, 23rd Apr 2021 12:04

(Sharecast News) - Stocks are holding lower at the end of the week despite very positive news out on the UK economy, after Bloomberg reported that Democrats on Capitol Hill want to double the US capital gains tax to nearly 39.6%.
"European markets are on the back foot in early trade, with valuations taking a dive in the wake of Joe Biden's proposal to implement a near 50% stamp duty rate on high earners. With the past year having seen traders react with glee over repeated bouts of stimulus, traders are gradually seeing the uncomfortable truth that those debts have to be paid one way or another," said Josh Mahony, senior market analyst at IG.

"Quite whether Biden manages to garner enough support to pass this bill remains to be seen, with the president likely to require almost unanimous support from the Democrats given the expected widespread rejection from the GOP."

Another key consideration according to experts was whether any tax hikes would be applied retroactively to 2021.

Against that backdrop, as of 1205 BST the FTSE 100 was trading lower by 0.48% or 33.12 points to 6,905.04, while the second-tier index was down by 0.22% or 49.39 points at 22,315.48.

Futures tracking the S&P 500 on the other hand were now bouncing back by 11.5 points to 4,139.25.

Sterling was higher alongside too, adding 0.33% to 1.3885.

Barrage of positive economic data

The news on the economic front nevertheless was surprisingly positive.

According to the Office for National Statistics, UK retail sales surged at a month-on-month pace of 5.4% in March (consensus: 1.5%).

That was despite non-essential stores having remained shut until 12 April.

IHS Markit's Purchasing Managers Indices for factory and services also came in ahead of forecasts for April, with record levels of optimism for the year ahead "setting the scene for a bumper second quarter for the economy".

Consultancy GfK meanwhile reported an improvement in its UK consumer confidence index from -16 for March to -15 in April, although shoppers appeared to be returning "quite tentatively" to stores, said Samuel Tombs at Pantheon Macroeconomics.

Public sector net borrowing data for March also came in better than expected, at £28.0bn (consensus: £22.0bn), for total 2020/21 fiscal year borrowing £303.1bn or 14.5% of GDP, the most since WWII, but in any case than the OBR's projection for £354.6bn in the March budget.

First Group sells US assets to lower debt pile

FirstGroup has agreed to sell its First Student and First Transit US bus businesses to EQT Infrastructure for an enterprise value of £3.3bn. The UK transport group said it would use £2.19bn of initial net proceeds to cut debt, pay into its pension schemes and return £365m, or 30p a share, to shareholders during 2021.

GlaxoSmithKline said the US Food and Drug Administration (FDA) has approved 'Jemperli', or dostarlimab-gxly, based on its Biologics License Application. The AIM-traded firm said dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody, is indicated for the treatment of adult patients with mismatch repair-deficient recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that have progressed on or following prior treatment with a platinum-containing regimen. It said the indication was given accelerated approval based on tumour response rate and durability of response.

LondonMetric Property has sold two long income assets let to Marks & Spencer and Wickes in Derby for a combined £11.1m to unnamed buyers. The sale represents a blended net initial yield of 6% and a 7% surplus to the last reported book value. One property is a M&S Foodhall, sold by way of a forward commitment to an overseas private investor for £6.2m and the other a Wickes store, sold to an overseas property company for £4.9m.

Market Movers

FTSE 100 (UKX) 6,908.47 -0.43%
FTSE 250 (MCX) 22,309.18 -0.25%
techMARK (TASX) 4,346.48 -0.39%

FTSE 100 - Risers

Intertek Group (ITRK) 6,252.00p 1.86%
Taylor Wimpey (TW.) 187.55p 1.49%
Evraz (EVR) 639.40p 1.46%
Just Eat Takeaway.Com N.V. (CDI) (JET) 7,956.00p 1.26%
Glencore (GLEN) 295.90p 1.16%
Flutter Entertainment (CDI) (FLTR) 15,075.00p 1.14%
Smith (DS) (SMDS) 417.10p 0.97%
Anglo American (AAL) 3,119.50p 0.82%
InterContinental Hotels Group (IHG) 5,148.00p 0.82%
WPP (WPP) 960.00p 0.80%

FTSE 100 - Fallers

International Consolidated Airlines Group SA (CDI) (IAG) 196.08p -2.20%
Next (NXT) 7,880.00p -2.11%
Hargreaves Lansdown (HL.) 1,667.50p -1.74%
Diageo (DGE) 3,260.00p -1.70%
Hikma Pharmaceuticals (HIK) 2,396.00p -1.68%
Reckitt Benckiser Group (RKT) 6,691.00p -1.62%
Smith & Nephew (SN.) 1,470.00p -1.47%
United Utilities Group (UU.) 953.40p -1.47%
Sainsbury (J) (SBRY) 245.30p -1.37%
Auto Trader Group (AUTO) 569.00p -1.35%

FTSE 250 - Risers

FirstGroup (FGP) 92.55p 8.75%
SSP Group (SSPG) 337.90p 2.83%
Network International Holdings (NETW) 430.00p 2.38%
National Express Group (NEX) 324.00p 2.02%
Crest Nicholson Holdings (CRST) 415.80p 2.01%
Fidelity China Special Situations (FCSS) 438.00p 1.86%
Mitchells & Butlers (MAB) 310.80p 1.83%
Restaurant Group (RTN) 124.80p 1.79%
Vistry Group (VTY) 1,232.00p 1.73%
XP Power Ltd. (DI) (XPP) 5,230.00p 1.55%

FTSE 250 - Fallers

Workspace Group (WKP) 801.50p -4.13%
AO World (AO.) 285.80p -3.18%
AJ Bell (AJB) 437.00p -2.85%
Capita (CPI) 42.73p -2.67%
easyJet (EZJ) 984.80p -2.64%
Beazley (BEZ) 328.30p -2.55%
Carnival (CCL) 1,637.20p -2.28%
CMC Markets (CMCX) 491.00p -2.00%
IWG (IWG) 349.90p -1.85%
Allianz Technology Trust (ATT) 2,940.00p -1.84%
More News
Today 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.